[1
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif,
France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France.
[4] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore
di Sanità, Rome, Italy.
[2
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif,
France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France.
[3
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté
de Médecine, Le Kremlin Bicêtre, France. [3] INSERM, U848, Villejuif, France.
[4
]
1] INSERM, U848, Villejuif, France. [2] Equipe 11 Labellisée par la Ligue Nationale
Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. [3] Université
Paris Descartes, Sorbonne Paris Cité, Paris, France.
[5
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and
Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [3] Department of Medical
Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
[6
]
Regina Elena National Cancer Institute, Rome, Italy.
[7
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U981, Villejuif, France.
[8
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif,
France. [3] Transgene S.A., Illkirch-Graffenstaden, France.
[9
]
Laboratory for Genomics and Immunoregulation, Life and Medical Sciences (LIMES), University
of Bonn, Bonn, Germany.
[10
]
Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital
Bonn, Bonn, Germany.
[11
]
Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità,
Rome, Italy.
[12
]
1] SIB-Swiss Institute of Bioinformatics, Lausanne, Switzerland. [2] National Center
of Competence in Research (NCCR) Molecular Oncology, Institut Suisse de Recherche
Expérimentale sur le Cancer (ISREC), School of Life Sciences, École Polytechnique
Fédérale de Lausanne (EPFL), Lausanne, Switzerland. [3] Departement de Formation et
Recherche, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
[13
]
Department of Pathology, Centre Claudius Regaud, Toulouse, France.
[14
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Medical Oncology,
Gustave Roussy Cancer Campus, Villejuif, France.
[15
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif,
France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507,
Villejuif, France. [4] Department of Medical Oncology, Hôpital Pitie Salpetriere,
Paris, France.
[16
]
Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France.
[17
]
Yale School of Medicine, New Haven, Connecticut, USA.
[18
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif,
France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507,
Villejuif, France.
[19
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and
Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
[20
]
Department of Pathology, Jean Perrin Center, EA 4677 ERTICa, University of Auvergne,
Clermont-Ferrand, France.
[21
]
1] Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
[2] INSERM, CRI-866 Faculty of Medicine, Dijon, France. [3] University of Burgundy,
Dijon, France.
[22
]
Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France.
[23
]
San Raffaele University and Scientific Institute, Milan, Italy.
[24
]
1] Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts,
USA. [2] Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts,
USA.
[25
]
Transgene S.A., Illkirch-Graffenstaden, France.
[26
]
CNRS UMR5235, University Montpellier II, Place Eugène Bataillon, Montpellier, France.
[27
]
Department of Pathology and Immunology, Washington University School of Medicine,
St. Louis, Missouri, USA.
[28
]
Queensland Institute of Medical Research, Herston, Queensland, Australia.
[29
]
1] Queensland Institute of Medical Research, Herston, Queensland, Australia. [2] School
of Medicine, The University of Queensland, Herston, Queensland, Australia.
[30
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté
de Médecine, Le Kremlin Bicêtre, France. [3] Department of Biology and Pathology,
Gustave Roussy Cancer Campus, Villejuif, France. [4] Department of Medical Oncology,
Gustave Roussy Cancer Campus, Villejuif, France. [5] INSERM, U981, Villejuif, France.
[31
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U848, Villejuif, France.
[3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. [4] Metabolomics
Platform, Gustave Roussy Cancer Campus, Villejuif, France. [5] Pôle de Biologie, Hôpital
Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
[32
]
1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté
de Médecine, Le Kremlin Bicêtre, France. [3] Center of Clinical Investigations in
Biotherapies of Cancer (CICBT) 507, Villejuif, France.